Fundz

ZBiotics raised $12M in a Series A funding round led by Spring Tide Capital to expand retail operations and further research in genetically engineered probiotics.

PRIVATEAug 27, 2024

Amount Raised

$12 Million

Round Type

Series A

San FranciscoBiotechnologyHealth Care

Investors

Seaside VenturesGoat Rodeo CapitalSeamless CapitalAccess CapitalSpring Tide Capital

Description

ZBiotics has closed a $12M Series A funding round, which will support its growth in consumer demand and product development. The round was led by Spring Tide Capital and included participation from several other investors.

Quick answer

ZBiotics Co raised $12 Million in a Series A round, dated August 27, 2024. Investors: Seaside Ventures, Goat Rodeo Capital, Seamless Capital, Access Capital and Spring Tide Capital. ZBiotics Co is based in San Francisco, California, United States.

How much did ZBiotics Co raise?
ZBiotics Co raised $12 Million in a Series A round on August 27, 2024.
Who invested in ZBiotics Co?
Seaside Ventures, Goat Rodeo Capital, Seamless Capital, Access Capital and Spring Tide Capital are named as investors in this round.
What does ZBiotics Co do?
Zack Abbott, PhD microbiologist, founded ZBiotics because of the potential genetically engineered probiotics have to improve daily living.
Where is ZBiotics Co based and how big is it?
ZBiotics Co is based in San Francisco, California, United States.
Who are the decision-makers at ZBiotics Co?
Fundz holds 1 contact at ZBiotics Co. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as ZBiotics Co that raised within 45 days of this round, from Fundz verified event records.

  • NewcelX raised $7.2M on October 11, 2024.
  • Booster Therapeutics raised $15M (Angel) on October 10, 2024.
  • Orasis Pharmaceuticals raised $78M (Series D) on October 10, 2024.
  • clock.bio raised $5.3M (Seed) on October 9, 2024.
  • MONCYTE Health raised $1.1M (Seed) on October 8, 2024.
  • City Therapeutics raised $135M (Series A) on October 8, 2024.

Who to call at ZBiotics Co, and when

A new round usually means ZBiotics Co is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ZBiotics Co raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ZBiotics Co, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ZBiotics Co. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ZBiotics Co

Location

44 Montgomery Street - Suite 300

San Francisco, California, United States

About

Zack Abbott, PhD microbiologist, founded ZBiotics because of the potential genetically engineered probiotics have to improve daily living. Our first product is a probiotic that helps you feel better the day after drinking alcohol. ZBiotics is leveraging its patented technology to create a whole new category of products that help our bodies deal with whatever modern life throws our way. It’s genetic engineering as it should be: transparent, responsible, and people first.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ZBiotics Co raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for ZBiotics Co's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

ZBiotics Co raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.